as on November 15, 2025 at 2:29 am IST
Day's Low
Day's High
3.75%
Downside
3.75%
Upside
52 Week's Low
52 Week's High
55.70%
Downside
244.37%
Upside
Check Bionexus Gene Lab Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$8.7M
EPS (TTM)
0Dividend Yield
0.00%
PE Ratio (TTM)
-3.58
Industry PE ratio
0PEG Ratio
0Return On Equity TTM
-34.37%
Track how Bionexus Gene Lab Corp P/E has moved over time to understand its valuation trends.
Bionexus Gene Lab Corp in the last 5 years
Lowest (-107.57x)
June 30, 2023
Industry (0.00x)
November 14, 2025
Today (-3.58x)
November 14, 2025
Highest (-1.96x)
June 30, 2025
Today’s Price to Earnings Ratio: -3.58x
Compare market cap, revenue, PE, and other key metrics of Bionexus Gene Lab Corp with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $8.7M | NA | -3.58 | -30.71% | |
| HOLD | $73.9B | 25.69% | 37.62 | 12.49% | |
| BUY | $85.5B | 39.96% | 33.63 | 11.05% | |
| BUY | $200.3B | 66.75% | 28.73 | 21.17% | |
| BUY | $58.5B | -0.32% | 23.96 | -3.28% |
The Bionexus Gene Lab Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Bionexus Gene Lab Corp investment value today
Current value as on today
₹1,46,804
Returns
₹46,804
(+46.8%)
Returns from Bionexus Gene Lab Corp Stock
₹41,563 (+41.56%)
Dollar Returns*
₹5,242 (+5.24%)
Search interest for Bionexus Gene Lab Corp Stock has increased by 2% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:2% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 2.13M → 2.26M (in $), with an average increase of 5.5% per quarter
Best in 1 Year
![]()
In the last 1 year, BGLC has outperformed top 5 stocks with highest market-cap in its industry
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -623.32K → -616.17K (in $), with an average increase of 1.2% per quarter
Against Peers
![]()
In the last 3 years, Ecolab Inc. has given 74.8% return, outperforming this stock by 171.2%
Price Dip
![]()
In the last 7 days, BGLC stock has moved down by -13.5%
| Organisation | Bionexus Gene Lab Corp |
| Headquarters | Menara UOA Bangsar, Kuala Lumpur, Malaysia, 59000 |
| Industry | Commercial Services |
| CEO | Mr. Su-Leng Tan |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Su-Leng Tan | CEO, President, Secretary & Director |
Ms. Set Fui Chong | Chief Financial Officer |
Mr. Kwan Wah Chan | Marketing Manager |
Mr. Too Kam Tham | Managing Director |
Bionexus Gene Lab Corp share price today is $4.53 as on at the close of the market. Bionexus Gene Lab Corp share today touched a day high of $4.7 and a low of $4.36.
Bionexus Gene Lab Corp share touched a 52 week high of $15.6 on and a 52 week low of $2.01 on . Bionexus Gene Lab Corp stock price today i.e. is closed at $4.53,which is 70.96% down from its 52 week high and 125.73% up from its 52 week low.
Bionexus Gene Lab Corp market capitalisation is $0.00T as on .
Indian investors can start investing in Bionexus Gene Lab Corp (BGLC) shares with as little as ₹88.74 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.40 in Bionexus Gene Lab Corp stock (as per the Rupee-Dollar exchange rate as on ).
Based on Bionexus Gene Lab Corp share’s latest price of $4.53 as on November 15, 2025 at 2:29 am IST, you will get 2.2075 shares of Bionexus Gene Lab Corp. Learn more about
fractional shares .